Sipai Health Technology Co (HKSE:00314) Forward Dividend Yield % : 0.00% (As of May. 28, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co Forward Dividend Yield %?

As of today (2024-05-28), the Forward Annual Dividend Yield of Sipai Health Technology Co is 0.00%.

As of today (2024-05-28), the Trailing Annual Dividend Yield of Sipai Health Technology Co is 0.00%.

HKSE:00314's Forward Dividend Yield % is not ranked ^*
in the Medical Distribution industry.
Industry Median: 2.82
* Ranked among companies with meaningful Forward Dividend Yield % only.

Sipai Health Technology Co's Dividends per Share for the six months ended in Dec. 2023 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Sipai Health Technology Co's Forward Dividend Yield %

For the Medical Distribution subindustry, Sipai Health Technology Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sipai Health Technology Co's Forward Dividend Yield % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's Forward Dividend Yield % falls into.

Sipai Health Technology Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Sipai Health Technology Co (HKSE:00314) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Sipai Health Technology Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sipai Health Technology Co (HKSE:00314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

AX1:Germany

Address

No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN

Website

https://www.medbankshealthtech.com

Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Executives

Chang Jimmy Ching-hsin	2201 Interest of corporation controlled by you
Jeneration Group Limited	2201 Interest of corporation controlled by you
Leung Catherine Ho Yan	2202 Interest of your spouse
Purple Panther	2201 Interest of corporation controlled by you
Ma Xuguang	2501 Other
Li Ji	2501 Other
Wise Approach Investments Limited	2101 Beneficial owner
Ark Trust (hong Kong) Limited	2301 Trustee
Jpmorgan Chase & Co.	2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd.	2101 Beneficial owner
Simul International Holdings Limited	2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines